Extracellular ATP Induces a Distorted Maturation of Dendritic Cells and Inhibits Their Capacity to Initiate Th1 Responses1
暂无分享,去创建一个
[1] F. Di Virgilio,et al. The P2 purinergic receptors of human dendritic cells: identification and coupling to cytokine release , 2000, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[2] Kenneth M. Murphy,et al. Dendritic cell regulation of TH1-TH2 development , 2000, Nature Immunology.
[3] L. Nguyen,et al. Role of Antigen-Presenting Cells in Mediating Tolerance and Autoimmunity , 2000, The Journal of experimental medicine.
[4] P. Ricciardi-Castagnoli,et al. Differential effects of corticosteroids during different stages of dendritic cell maturation , 2000, European journal of immunology.
[5] L. Adorini,et al. 1α,25-Dihydroxyvitamin D3 Inhibits Differentiation, Maturation, Activation, and Survival of Dendritic Cells Leading to Impaired Alloreactive T Cell Activation , 2000, The Journal of Immunology.
[6] Nina Bhardwaj,et al. Consequences of cell death: exposure to necrotic tumor cells , 2000 .
[7] C. Albanesi,et al. Human CD4+ T lymphocytes with remarkable regulatory functions on dendritic cells and nickel-specific Th1 immune responses. , 2000, The Journal of investigative dermatology.
[8] F. Di Virgilio,et al. Adenosine triphosphate-induced oxygen radical production and CD11b up-regulation: Ca(++) mobilization and actin reorganization in human eosinophils. , 2000, Blood.
[9] C. Szabó,et al. Inosine Inhibits Inflammatory Cytokine Production by a Posttranscriptional Mechanism and Protects Against Endotoxin-Induced Shock1 , 2000, The Journal of Immunology.
[10] G. Chrousos,et al. Ligand-Activation of the Adenosine A2a Receptors Inhibits IL-12 Production by Human Monocytes , 2000, The Journal of Immunology.
[11] Stefania Gallucci,et al. Natural adjuvants: Endogenous activators of dendritic cells , 1999, Nature Medicine.
[12] G. Schuler,et al. Human monocyte derived dendritic cells express functional P2X and P2Y receptors as well as ecto‐nucleotidases , 1999, FEBS letters.
[13] A. Sher,et al. The role of dendritic cells in the induction and regulation of immunity to microbial infection. , 1999, Current opinion in immunology.
[14] V. Diehl,et al. Expression and a role of functionally coupled P2Y receptors in human dendritic cells , 1999, FEBS letters.
[15] Chang‐you Wu,et al. Cholera Toxin Suppresses Interleukin (IL)-12 Production and IL-12 Receptor β1 and β2 Chain Expression , 1999, The Journal of experimental medicine.
[16] S. Goerdt,et al. Other functions, other genes: alternative activation of antigen-presenting cells. , 1999, Immunity.
[17] P. Kalinski,et al. Prostaglandin E2 induces the final maturation of IL-12-deficient CD1a+CD83+ dendritic cells: the levels of IL-12 are determined during the final dendritic cell maturation and are resistant to further modulation. , 1998, Journal of immunology.
[18] G Burnstock,et al. Receptors for purines and pyrimidines. , 1998, Pharmacological reviews.
[19] R. Steinman,et al. Dendritic cells and the control of immunity , 1998, Nature.
[20] V. Fadok,et al. Macrophages that have ingested apoptotic cells in vitro inhibit proinflammatory cytokine production through autocrine/paracrine mechanisms involving TGF-beta, PGE2, and PAF. , 1998, The Journal of clinical investigation.
[21] S. Endres,et al. Anti‐inflammatory activities of cAMP‐elevating agents: enhancement of IL‐10 synthesis and concurrent suppression of TNF production , 1998, Journal of leukocyte biology.
[22] R. Voll,et al. Immunosuppressive effects of apoptotic cells , 1997, Nature.
[23] L. Fabbri,et al. Beta2-agonists prevent Th1 development by selective inhibition of interleukin 12. , 1997, The Journal of clinical investigation.
[24] F. Di Virgilio,et al. Extracellular ATP triggers IL-1 beta release by activating the purinergic P2Z receptor of human macrophages. , 1997, Journal of immunology.
[25] A. Giannetti,et al. Granulocyte macrophage colony-stimulating factor is overproduced by keratinocytes in atopic dermatitis. Implications for sustained dendritic cell activation in the skin. , 1997, The Journal of clinical investigation.
[26] M. Moser,et al. Effect of interleukin‐10 on dendritic cell maturation and function , 1997, European journal of immunology.
[27] D. Ferrari,et al. Purinoceptor function in the immune system , 1996 .
[28] H. Zimmermann,et al. Extracellular purine metabolism , 1996 .
[29] G. Firestein,et al. Inhibition of TNF-alpha expression by adenosine: role of A3 adenosine receptors. , 1996, Journal of immunology.
[30] F. Di Virgilio,et al. An ATP-activated channel is involved in mitogenic stimulation of human T lymphocytes. , 1996, Blood.
[31] M. Moser,et al. Glucocorticoids down‐regulate dendritic cell function in vitro and in vivo , 1995, European journal of immunology.
[32] M. Sitkovsky,et al. Role of Extracellular ATP and P1 and P2 Classes of Purinergic Receptors in T‐cell Development and Cytotoxic T Lymphocyte Effector Functions , 1995, Immunological reviews.
[33] Laurie H Glimcher,et al. B7-1 and B7-2 costimulatory molecules activate differentially the Th1/Th2 developmental pathways: Application to autoimmune disease therapy , 1995, Cell.
[34] L. Aarden,et al. Prostaglandin-E2 is a potent inhibitor of human interleukin 12 production , 1995, The Journal of experimental medicine.
[35] A. Giannetti,et al. Epidermal Langerhans cells are resistant to the permeabilizing effects of extracellular ATP: in vitro evidence supporting a protective role of membrane ATPase. , 1993, The Journal of investigative dermatology.
[36] C Caux,et al. Immunobiology of dendritic cells. , 2000, Annual review of immunology.
[37] L Adorini,et al. The interleukin-12/interleukin-12-receptor system: role in normal and pathologic immune responses. , 1998, Annual review of immunology.
[38] L. Fabbri,et al. Beta 2 agonists prevent Th1 development by selective inhibition of IL-12 , 1997 .
[39] F. Di Virgilio. The P2Z purinoceptor: an intriguing role in immunity, inflammation and cell death. , 1995, Immunology today.
[40] G. Burnstock,et al. Purinoceptors: are there families of P2X and P2Y purinoceptors? , 1994, Pharmacology & therapeutics.